Integrating Stakeholder Preferences in Comparative Effectiveness - - PowerPoint PPT Presentation
Integrating Stakeholder Preferences in Comparative Effectiveness - - PowerPoint PPT Presentation
Integrating Stakeholder Preferences in Comparative Effectiveness Research: Potential Uses of Multi-Criteria Decision Analysis Techniques August 27, 2012 Community Forum Moderator: Penny Mohr Vice President for Program Development, Cent
Community Forum
Community Forum Community Forum
Vice President for Program Development,
Cent er for Medical Technology Policy
AHRQ’s Communit y Forum proj ect Expert ise in st akeholder engagement and
comparat ive effect iveness research
Moderator: Penny Mohr
Community Forum
Community Forum Community Forum
Underst and different formal st ruct ured approaches t o
elicit ing and quant ifying st akeholder preferences
Compare and cont rast Conj oint Analysis and Analyt ic
Hierarchy Processes as preference assessment t ools
Describe applicat ions of preference met hods t o inform
Comparat ive Effect iveness Research (CER)
Goals
Community Forum
Community Forum Community Forum
AHRQ Community Forum
To expand st akeholder involvement in comparat ive
effect iveness research in AHRQ’ s Effect ive Healt h Care Program
To advance met hods for gat hering public input on value-
based healt hcare quest ions
Community Forum
Community Forum Community Forum
“ … The purpose of CER is to assist consumers, clinicians, purchasers and policy makers to make informed decisions that will improve health care at both the individual and population levels.”
Comparative Effectiveness Research
~Institute of Medicine, 2009
Community Forum
Community Forum
Categories of CER Methods
S
ystematic reviews of existing research
Decision modeling, with or without cost information Retrospective analysis of existing clinical or
administrative data
Prospective non-experimental studies, including
registries
Experimental studies, including randomized clinical
trials (RCTs)
Community Forum
Community Forum Community Forum
Ident ifying maj or gaps in exist ing research S
et t ing research priorit ies
Refining research quest ions Developing st udy prot ocols Translat ing research findings S
hared decision making
Activities of CER
Community Forum
Community Forum Community Forum
Chair, Depart ment of Healt h Technology & S
ervices Research, Universit y of Twent e, Net herlands.
Expert ise in pat ient report ed out comes, elicit at ion of
pat ient preferences in HTA, mult iple crit eria decision making and discret e choice met hods.
Dr. IJzerman will provide an int roduct ion t o
Mult i-crit eria decision models used for healt hcare decision making.
Speaker: Maarten IJzerman, PhD
Community Forum
Community Forum Community Forum
Professor of Medicine & Public Healt h &
Associat e Vice President for Populat ion Healt h S ciences, in t he Office of Healt h Affairs at t he Universit y of Illinois Hospit al & Healt h S ciences S yst em.
Chair of t he S
t eering Commit t ee for t he COPD Out comes-based Net work for Clinical Effect iveness and Research Translat ion (CONCERT).
Dr. Krishnan will describe t he applicat ion of Analyt ic
Hierarchy Process (AHP) to identify patient, clinician & other
stakeholder preferences for CER in COPD.
Speaker: Jerry Krishnan, MD, PhD
Community Forum
Community Forum Community Forum
Dist inguished Fellow and principal economist at Research
Triangle Inst it ut e (RTI).
Chair of t he IS
POR Conj oint Analysis (CA) Experiment al Design Task Force.
Dr. Johnson will describe t he applicat ion of CA for
elicit ing pat ient preferences about healt h out comes t o guide t he design of a st udy prot ocol.
Speaker: F. Reed Johnson, PhD
Community Forum
Community Forum
Agenda
Introduction (Present er: Penny Mohr, Communit y Forum Team) 10:30-10:40 AM An introduction to the use of Analytical Hierarchy Process and Conjoint Analysis in health research (Present er: Maart en Ij zerman) 10:40-11:00 AM
(Last 5 minut es reserved f or Q&A)
The use of AHP to elicit stakeholder input for prioritizing research (Present er: Jerry Krishnan) 11:00-11:20 AM
(Last 5 minut es reserved f or Q&A)
The use of CA to elicit patient preferences in selecting treatment endpoints (Present er: F . Reed Johnson) 11:20-11:40 AM
(Last 5 minut es reserved f or Q&A)